Pharma

flu immune system virus influenza COVID infection

Fierce Pharma

Cidara snares BARDA award to boost R&D, production of flu asset

Cidara Therapeutics has secured federal backing to develop and produce its experimental flu preventive, dubbed CD388, in the U.S.

Fraiser Kansteiner Oct 3, 2025 10:10am

three triple doors opportunity cracked open ajar

89bio was left between a Roche and a hard place in buyout talks

Oct 2, 2025 9:55am

Novo

Novo vs. KBP Chapter 2: 'Anomalous' trial results

Oct 2, 2025 3:00am

puzzle pieces merger and acquisition business concept

Fierce Pharma

Halozyme buys Elektrofi for up to $900M

Oct 1, 2025 2:36pm

A ballpoint pen rests on top of a stack of documents ready for signing

Kyorin pens $105M pact for Japan rights to Hinge's lupus drug

Oct 1, 2025 6:40am

cardiovascular disease

Novo calls off $598M Heartseed collab, citing 'strategic reviews'

Sep 30, 2025 1:55pm